Showing results (731-740 of 1,600) with videos related to

Sort By:
Pageof 160
RSC Medicinal Chemistry|May 23, 2025
Design, synthesis and antitumor activity evaluation of novel IMPDH II and HDAC1 dual inhibitorFang-Bo Deng, Hong-Wei Jia, De-Xiang Hu, et al.
RSC Medicinal Chemistry|April 30, 2026
Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxiaJames P Holt-Martyn, Nicole Machado, James T T Coates, et al.
RSC Medicinal Chemistry|April 22, 2026
Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studiesDong Xu, Wenxiu Weng, Huining Cao, et al.
RSC Medicinal Chemistry|July 13, 2026
From dual norepinephrine-dopamine reuptake inhibition to selective dopamine reuptake inhibitors: a case of aromatically substituted N,2-cyclopentylaminesMajlen A Dilweg, Willem Jespers, Ameya S Kasture, et al.
RSC Medicinal Chemistry|July 14, 2026
Development of a novel series of methylene disalicylic acid derivatives as antibacterial agents targeting DNA gyrase and/or topoisomerase IVLamya H Al-Wahaibi, Safwat M Rabea, Hayat Ali Alzahrani, et al.
RSC Medicinal Chemistry|July 14, 2026
Research progress regarding iminosugars for glycosidase inhibition and hypoglycemic activityChao-Na An, Mei-Qi Yang, Xin-Ran Song, et al.
RSC Medicinal Chemistry|June 19, 2026
Rational design of an environment-sensitive fluorescent probe for monitoring butyrylcholinesterase activity and its application in Alzheimer's diseaseNing Guo, Feng Wang, Yu Wang, et al.
RSC Medicinal Chemistry|June 25, 2026
Design, synthesis, and in silico and in vitro evaluation of novel complex naphthalimide-ciprofloxacin hybrids as next-generation antimicrobial agentsDharmendra Singh, Ankita Singh, Harikesh Kumar Gupta, et al.
RSC Medicinal Chemistry|June 24, 2026
Design and synthesis of N-3-substituted quinazolinone derivatives as anticancer agents targeting EGFRPritam Maity, Poonam Yadav, Joydeep Chatterjee, et al.
RSC Medicinal Chemistry|June 4, 2026
Identification and structure-activity relationship analysis of minimal fusion inhibitors targeting measles virus F proteinKazuya Kobayashi, Yuki Yamaguchi, Mizuki Itahara, et al.
Pageof 160